Elixir Pharmaceuticals Withdraws IPO Plans Published: May 12, 2008 WASHINGTON, May 9 (Reuters) - Elixir Pharmaceuticals Inc on Friday filed with regulators to withdraw its plans for an initial public offering due to "market conditions." Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news